Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vestipitant and Paroxetine in Social Anxiety Disorder
NCT00403962Phase 2Completed
- Sponsor
- GSK
- Start
- Nov 2004
- Modality
- Orthosteric Ligands
- Countries
- 4
01
Overview
Phase 2, randomised, double-blind trial of vestipitant in Social Anxiety Disorder (SAD) (3 arms), sponsored by GSK. Primary endpoint: Change in score on a Social Anxiety Disorder rating scale at 12 weeks. Started Nov 2004; status: completed.
02
Drugs
vestipitant
03
Conditions
Social Anxiety Disorder (SAD)
Beyond the preview
Go deeper on NCT00403962.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00403962.